HELIX, INC. for HELIX, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 3, 2022 | $36,520 | Replaced |
| 3rd Quarter - Amendment (this page) | Aug 3, 2023 | $130,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to Human and Viral Genomic research, testing,funding and insurance coverage for hereditary cancer screening and treatment,opportunities for pharmacogenomic testing, pandemic preparedness, viral surveillance, and regulation of Lab Developed Tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Medical/Disease Research/Clinical Labs MED
viral and human genomic research, testing,funding and insurance coverage, COVID-19 testing and research surveillance, sequencing and development of medical countermeasures for pathogens of pandemic potential Regulation Lab Developed Tests through VALID Act USH4128
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES New | — |
Budget/Appropriations BUD
Continued use of Covid Supplemental funding for viral surveillance, sequencing blood and spital samples, and PCR testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.